• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Eli Lilly and Co

    Recent news which mentions Eli Lilly and Co

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
    Tags Markets Eisai Co Ltd stocks
    From CNBC.com News
    FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
    Tags Biotechnology Business News Biotech and Pharmaceuticals
    From CNBC.com News
    Jim Cramer's week ahead: Fed meeting and CPI report
    Tickers RH
    Tags stocks Affirm Holdings Inc Eli Lilly and Co
    From CNBC.com News
    Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
    Tags Biotech and Pharmaceuticals Pfizer Inc Healthy Returns
    From CNBC.com News
    Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
    Tags Internet Eli Lilly and Co Technology
    From CNBC.com News
    Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
    Tags Eli Lilly and Co Alphabet Inc Technology
    From CNBC.com News
    Why half of all workers may struggle to get weight-loss drug health insurance coverage
    Tags Small Business: Management Social issues Employee healthcare benefits
    From CNBC.com News
    Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
    Tags Health care industry Pharmaceuticals Business
    From CNBC.com News
    This new weight loss drug ETF bets big on two of the industry's leading players
    Tags Investing Zealand Pharma A/S Eli Lilly and Co
    From CNBC.com News
    How digital health companies are capitalizing on the GLP-1 boom
    Tags Hospitals Novo Nordisk A/S Mobile
    From CNBC.com News
    Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
    Tags Business Health & Science Pharmaceuticals
    From CNBC.com News
    Cramer's Lightning Round: Sigma Lithium is 'too dicey'
    Tags Eli Lilly and Co Arista Networks Inc Investing
    From CNBC.com News
    This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
    Tags Health & Science Eli Lilly and Co AstraZeneca PLC
    From CNBC.com News
    Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
    Tags Uber Technologies Inc Eli Lilly and Co Health & Science
    From CNBC.com News
    Roche says weight loss drug shows promising results in early trial
    Tags Health & Science Roche Holding AG Eli Lilly and Co
    From CNBC.com News
    Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
    Tags Science Health & Science Health care industry
    From CNBC.com News
    People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
    Tags Health & Science Eli Lilly and Co US: News
    From CNBC.com News
    Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
    Tags Microsoft Corp Tesla Inc Technology
    From CNBC.com News
    Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
    Tags Biotech and Pharmaceuticals Apple Inc Healthy Returns
    From CNBC.com News
    Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
    Tags Biotechnology Amgen Inc Altimmune Inc
    From CNBC.com News
    Within a few years, generative AI will be designing new drugs all on its own
    Tags Artificial intelligence AI / Artificial Intelligence Biotech and Pharmaceuticals
    From CNBC.com News
    Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
    Tags Biotechnology Amgen Inc Health & Science
    From CNBC.com News
    Wegovy maker Novo Nordisk down 4%, heads for worst day since October
    Tags Europe News LVMH Moet Hennessy Louis Vuitton SE Biotech and Pharmaceuticals
    From CNBC.com News
    Amgen scraps experimental weight loss pill, moves forward with injection
    Tags Business News Novo Nordisk A/S Breaking news
    From CNBC.com News
    Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
    Tags Breaking news Business News Biotech and Pharmaceuticals
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags ON Semiconductor Corp CVS Health Corp Advanced Micro Devices Inc
    From CNBC.com News
    Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
    Tags Starbucks Corp Investment Strategy Business
    From CNBC.com News
    Most people on weight loss drugs are spending less on restaurants and takeout, survey says
    Tags Biotechnology Lifestyle Hershey Co
    From CNBC.com News
    Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
    Tags US: News Eli Lilly and Co Health & Science
    From CNBC.com News
    Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
    Tags Biotechnology Health & Science Eli Lilly and Co
    From CNBC.com News
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.